afmed 30mg tablet - Afatinib dimaleate (30mg) medicine

Afzeta 30mg Tablet (Afatinib Dimaleate) - Comprehensive Medicine Guide

No reviews yet
🏭 Medicamen Biotech Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Oct 16, 2026
⚠️ Hepatotoxicity Risk ⚠️ Nephrotoxicity Risk 🤰 Pregnancy Category This medicine can cause fetal harm when administered to a pregnant woman. Based on its mechanism of action and animal studies, it is expected to be teratogenic and embryotoxic. Women of childbearing potential should use effective contraception during treatment and for at least 2 weeks after the last dose. If pregnancy occurs during treatment, the patient should be informed of the potential hazard to the fetus. 📋 Prescription Required 💊 Generic Available
Medically Reviewed
12 min read
Evidence: High for approved indications.
Reviewed by
SaathiMed Expert Panel | Oct 16, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026

When to Call Your Doctor IMMEDIATELY

  • Severe diarrhea with dehydration, dizziness, or decreased urination
  • New or worsening cough, shortness of breath, or fever
  • Painful skin rash with blisters or peeling, especially with mouth sores
  • Yellowing of skin or eyes, dark urine, or severe abdominal pain
  • Eye pain, redness, blurred vision, or excessive tearing
  • Severe abdominal pain with fever or changes in bowel habits
  • Unusual bleeding or bruising
  • Swelling of face, lips, or throat

If experiencing severe symptoms, call emergency services immediately.

What is afmed 30mg tablet used for?

This medicine is a targeted therapy used to treat non-small cell lung cancer with specific EGFR mutations. It works by blocking proteins that help cancer cells grow. It is taken orally once daily.

  • Generic Name: Afatinib
  • Manufacturer: Medicamen Biotech Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 afmed 30mg tablet के बारे में (Hindi Summary)

उपयोग: यह दवा मुख्य रूप से फेफड़ों के कैंसर (नॉन-स्मॉल सेल लंग कैंसर) के इलाज के लिए इस्तेमाल की जाती है, खासकर उन मरीजों में जिनके ट्यूमर में EGFR जीन में म्यूटेशन होता है। यह एक टार्गेटेड थेरेपी है जो कैंसर कोशिकाओं की वृद्धि को रोकती है। यह मुंह से ली जाती है और आमतौर पर दिन में एक बार ली जाती है। यह दवा कैंसर विशेषज्ञ की देखरेख में ही लेनी चाहिए।

साइड इफेक्ट्स: इस दवा के आम दुष्प्रभावों में दस्त, त्वचा पर दाने, मुंह के छाले, नाखूनों में बदलाव, भूख कम लगना, जी मिचलाना और थकान शामिल हैं। कुछ गंभीर दुष्प्रभाव भी हो सकते हैं जैसे गंभीर दस्त, निर्जलीकरण, फेफड़ों में सूजन, लीवर की समस्या, आंखों की समस्या और त्वचा पर गंभीर प्रतिक्रियाएं। अगर कोई भी गंभीर लक्षण दिखे तो तुरंत डॉक्टर से संपर्क करें।

सुरक्षा सलाह: इस दवा को डॉक्टर के बताए अनुसार ही लें। दिन में एक बार नियमित समय पर लें। दस्त होने पर पानी और तरल पदार्थ का सेवन अधिक करें। धूप से बचें और सनस्क्रीन का इस्तेमाल करें। गर्भवती महिलाएं या गर्भधारण की योजना बना रही महिलाएं इस दवा का सेवन न करें। स्तनपान कराने वाली महिलाएं भी इस दवा का सेवन न करें। अन्य दवाओं के साथ इस दवा का सेवन करने से पहले डॉक्टर से सलाह लें। नियमित रूप से लीवर और किडनी की जांच कराते रहें।

💡 Did You Know? Over 80% of the antiretroviral drugs used globally to combat AIDS are supplied by Indian pharmaceutical companies.

💊 afmed 30mg tablet Uses & Benefits

[{"condition":"EGFR mutation-positive non-small cell lung cancer (NSCLC)","description":"Used as first-line treatment in patients with locally advanced or metastatic NSCLC whose tumors have certain EGFR mutations (e.g., exon 19 deletions or exon 21 L858R substitution).","evidence":"Well-established"},{"condition":"Squamous cell carcinoma of the lung","description":"Used in patients with advanced squamous NSCLC that has progressed after platinum-based chemotherapy.","evidence":"Established"},{"condition":"HER2-positive breast cancer","description":"Used in combination with other agents in certain patients with HER2-positive metastatic breast cancer after prior treatments.","evidence":"Limited"},{"condition":"Head and neck cancer","description":"Sometimes used in clinical trials or off-label for recurrent or metastatic head and neck squamous cell carcinoma.","evidence":"Investigational"}]

Off-label uses: [{"condition":"Other EGFR-mutated solid tumors","description":"Occasionally used off-label for other cancers with EGFR mutations, such as glioblastoma or colorectal cancer, based on molecular profiling.","evidence":"Limited"}]

Primary treatment for: EGFR mutation-positive non-small cell lung cancer (NSCLC)

Also treats: Squamous cell carcinoma of the lung, HER2-positive breast cancer

📋 Drug Information

Generic Name(s)Afatinib
Brand NameAfzeta 30mg Tablet
ManufacturerMedicamen Biotech Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassANTI NEOPLASTICS
Action ClassTyrosine kinase inhibitors
Route of AdministrationOral
StorageStore at room temperature between 20°C and 25°C (68°F to 77°F). Excursions permitted to 15°C to 30°C (59°F to 86°F). Keep in the original container to protect from moisture and light. Do not remove the desiccant. Keep out of reach of children.
Shelf LifeRefer to the expiration date printed on the package. Do not use after the expiry date.
WHO GuidelineNot established from the available information.
ICMR GuidelineNot established from the available information.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Take this medicine at the same time each day to maintain consistent blood levels.
2
Monitor for diarrhea closely; start anti-diarrheal medication at the first sign of loose stools as advised by your doctor.
3
Use moisturizers and sunscreen daily to manage skin dryness and rash.
4
Report any new or worsening respiratory symptoms immediately, as they may indicate lung toxicity.
5
Regular blood tests for liver and kidney function are essential during treatment.
6
Avoid grapefruit juice and St. John's wort while taking this medicine.
7
Use effective contraception during treatment and for at least 2 weeks after the last dose.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
Chronic cough with EGFR mutation-positive lung cancer
This medicine is prescribed for this condition.
Likely Use
❌
Skin rash
This medicine can cause skin rash as a side effect, not as a treatment.
Not Primary
❌
Diarrhea
This medicine can cause diarrhea as a side effect.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionFollowing oral administration, afatinib is absorbed slowly, with peak plasma concentrations occurring approximately 2 to 5 hours after ingestion. The absolute bioavailability is approximately 59% in healthy volunteers. Food does not significantly affect the extent of absorption, but a high-fat meal can reduce the peak concentration and delay the time to peak. Therefore, this medicine can be taken with or without food.
DistributionAfatinib is extensively distributed into body tissues. The apparent volume of distribution is approximately 4500 L, indicating wide distribution. It is highly bound to plasma proteins, primarily albumin and alpha-1 acid glycoprotein.
Protein BindingApproximately 95% bound to plasma proteins.
MetabolismAfatinib is metabolized primarily by enzymatic reactions, including conjugation with glutathione, and to a lesser extent by cytochrome P450 enzymes. It undergoes extensive metabolism, but the metabolites are not considered to contribute significantly to its activity. The main metabolite is a glutathione conjugate.
Half-LifeThe terminal elimination half-life of afatinib is approximately 28 to 37 hours, supporting once-daily dosing.
ExcretionAfatinib is primarily excreted in the feces (approximately 85% of the dose), with about 4% excreted in the urine. The majority of the dose is eliminated as unchanged drug or metabolites.
BioavailabilityThe absolute bioavailability of afatinib is approximately 59% after oral administration.
Onset of ActionThe onset of action is not immediate; clinical effects such as tumor response may take several weeks to become evident. However, side effects like diarrhea and rash can occur within days to weeks of starting treatment.
Peak Plasma TimePeak plasma concentrations are reached approximately 2 to 5 hours after oral administration.
Duration of ActionThe duration of action is prolonged due to irreversible binding, but the clinical effect is typically assessed over weeks to months. The half-life supports once-daily dosing.

How It Works

This medicine is an irreversible inhibitor of the ErbB family of receptor tyrosine kinases, including EGFR (ErbB1), HER2 (ErbB2), ErbB3, and ErbB4. It covalently binds to the ATP-binding site of these receptors, leading to irreversible inhibition of autophosphorylation and downstream signaling. This results in inhibition of cell proliferation, induction of apoptosis, and reduction of angiogenesis and metastasis. The irreversible binding distinguishes it from reversible inhibitors and may lead to prolonged effects.

Mechanism Steps

1
Binding to ErbB receptors: This medicine covalently binds to the ATP-binding pocket of EGFR, HER2, ErbB3, and ErbB4, forming an irreversible bond.
2
Inhibition of autophosphorylation: The irreversible binding prevents autophosphorylation of the receptors, blocking activation of downstream signaling pathways.
3
Blockade of downstream signaling: This leads to inhibition of pathways such as MAPK and PI3K/AKT, which are involved in cell proliferation and survival.
4
Induction of apoptosis and growth arrest: Cancer cells undergo programmed cell death and stop dividing, resulting in tumor shrinkage.
5
Anti-angiogenic and anti-metastatic effects: Inhibition of ErbB signaling also reduces angiogenesis and the potential for metastasis.

💡 How to Take afmed 30mg tablet

Strength: This medicine is available as a 30 mg immediate-release tablet for oral administration.

1Take this medicine at the same time each day.
2Swallow the tablet whole with a glass of water.
3You may take it with or without food.
4Do not crush, chew, or split the tablet.
5If you miss a dose, follow the missed dose instructions.
6Do not take extra doses to make up for a missed one.
7Stay hydrated, especially if you experience diarrhea.

Dosage Information

Adult DosageThe recommended adult dose of this medicine is 40 mg orally once daily for first-line treatment of EGFR mutation-positive non-small cell lung cancer. For squamous NSCLC after platinum-based chemotherapy, the recommended dose is 40 mg once daily. For HER2-positive breast cancer, the dose may be 40 mg once daily with other agents. Dose reductions to 30 mg or 20 mg may be required for adverse reactions. Dose must be individualized by a qualified clinician based on indication, age, weight, renal and hepatic function, and tolerability.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatric oncologist.
Elderly DosageNo specific dose adjustment is recommended based on age alone. However, elderly patients may be more susceptible to adverse effects such as diarrhea and dehydration. Monitor closely and adjust dose as needed based on tolerability and organ function.
Renal ImpairmentFor patients with severe renal impairment (creatinine clearance <30 mL/min), the recommended dose is 30 mg once daily. For moderate renal impairment (creatinine clearance 30-59 mL/min), no initial dose adjustment is required, but monitor closely. For mild renal impairment, no adjustment is needed.
Hepatic ImpairmentFor patients with severe hepatic impairment (Child-Pugh C), the recommended dose is 30 mg once daily. For moderate hepatic impairment (Child-Pugh B), no initial dose adjustment is required, but monitor closely. For mild hepatic impairment, no adjustment is needed.
Maximum Daily DoseThe maximum recommended daily dose is 40 mg once daily. Dose reductions may be necessary for toxicity.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

With or without food
Take at the same time each day
Food does not significantly affect absorption.
Grapefruit juice
Avoid
May increase drug levels and toxicity.
High-fat meal
May reduce peak levels
No significant clinical impact, but consistency is advised.

⏰ What to Do If You Miss a Dose

📌 Less than 12 hours since missed dose
→ Take the missed dose as soon as you remember.
💡 Continue with the regular schedule.
📌 More than 12 hours since missed dose
→ Skip the missed dose.
💡 Do not double dose to catch up.

⚠️ Side Effects of afmed 30mg tablet

✅ Common Side Effects

Diarrhea (Very common (>10%))
Drink plenty of fluids, take anti-diarrheal medication as prescribed by your doctor, and report if it persists or worsens.
Skin rash (acneiform) (Very common (>10%))
Use gentle skin care, avoid harsh soaps, and apply moisturizer. Your doctor may prescribe topical or oral antibiotics or steroids.
Dry skin (Common (1-10%))
Use moisturizing creams and avoid hot showers.
Itching (Common (1-10%))
Keep skin moisturized, avoid scratching, and consult your doctor if severe.
Mouth sores (stomatitis) (Common (1-10%))
Maintain good oral hygiene, use a soft toothbrush, and rinse with salt water or prescribed mouthwash.
Nail changes (paronychia) (Common (1-10%))
Keep nails clean and dry, avoid cutting cuticles, and report signs of infection.
Decreased appetite (Common (1-10%))
Eat small, frequent meals and consult a dietitian if needed.
Nausea (Common (1-10%))
Take with food, and your doctor may prescribe anti-nausea medication.
Fatigue (Common (1-10%))
Get adequate rest, pace activities, and report if severe.

🚨 Serious Side Effects

Severe diarrhea with dehydration (Uncommon (0.1-1%))
Seek immediate medical attention if you have severe diarrhea, dizziness, or decreased urination.
Interstitial lung disease (pneumonitis) (Rare (<0.1%))
Report new or worsening cough, shortness of breath, or fever immediately.
Severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) (Rare (<0.1%))
Seek immediate medical attention if you develop a painful rash with blisters, peeling skin, or sores in the mouth or eyes.
Liver toxicity (hepatitis, hepatic failure) (Uncommon (0.1-1%))
Report yellowing of skin or eyes, dark urine, or abdominal pain. Regular liver function tests are required.
Eye problems (keratitis, conjunctivitis) (Uncommon (0.1-1%))
Report eye pain, redness, blurred vision, or excessive tearing immediately.
Gastrointestinal perforation (Rare (<0.1%))
Seek immediate medical attention for severe abdominal pain, fever, or changes in bowel habits.
Pancreatitis (Rare (<0.1%))
Report severe abdominal pain radiating to the back, with nausea and vomiting.

⚠️ Rare Side Effects

Cardiac toxicity (reduced ejection fraction, cardiomyopathy)
Report shortness of breath, swelling in legs, or fatigue. Regular cardiac monitoring may be needed.
Renal failure
Report decreased urine output or swelling. Monitor kidney function regularly.
Thrombocytopenia
Report unusual bleeding or bruising. Blood counts should be monitored.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Ritonavir Major
Rifampicin Major
Ketoconazole Major
Cyclosporine Major
Verapamil Major
Carbamazepine Major
Phenytoin Major
St. John's wort Major
Omeprazole Moderate
Ranitidine Moderate

🚨 Major Interactions

  • P-glycoprotein (P-gp) inhibitors (e.g., ritonavir, cyclosporine, ketoconazole, itraconazole, quinidine, verapamil)
  • P-glycoprotein (P-gp) inducers (e.g., rifampicin, carbamazepine, phenytoin, St. John's wort)

⚡ Moderate Interactions

  • Proton pump inhibitors (e.g., omeprazole)
  • H2 receptor antagonists (e.g., ranitidine)

🍷 Alcohol Interaction

Alcohol may worsen side effects such as nausea, dizziness, and fatigue. It is advisable to avoid or limit alcohol consumption while taking this medicine.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Known severe hypersensitivity to afatinib or any component of the formulation","Pregnancy (due to risk of fetal harm)","Breastfeeding (due to potential serious adverse reactions in infants)","Severe hepatic impairment (Child-Pugh C) without dose adjustment","Severe renal impairment (creatinine clearance

⚠️ Warnings & Precautions

["Diarrhea: May be severe and lead to dehydration, renal failure, and electrolyte imbalances. Monitor and treat promptly.","Skin reactions: Severe bullous, blistering, and exfoliative skin disorders have occurred. Discontinue if life-threatening.","Interstitial lung disease (ILD): Has been reported; discontinue if ILD is suspected.","Hepatotoxicity: Monitor liver function; dose interruption or discontinuation may be required.","Gastrointestinal perforation: Has been reported; discontinue if suspected.","Ocular disorders: Keratitis and conjunctivitis have been reported; refer to ophthalmologist if symptoms occur.","Embryo-fetal toxicity: Can cause fetal harm; advise contraception.","Renal impairment: Dose adjustment needed for severe renal impairment.","P-gp interactions: Avoid concomitant use with strong P-gp inhibitors or inducers; adjust dose if necessary."]

🤱 Lactation Safety

It is not known whether afatinib is present in human milk. Because of the potential for serious adverse reactions in breastfed infants, women should not breastfeed during treatment and for at least 2 weeks after the last dose.

💊 Overdose Management

There is no specific antidote for overdose with this medicine. In case of suspected overdose, treatment should be symptomatic and supportive. Gastric lavage may be considered if ingestion is recent. Monitor vital signs and provide appropriate supportive care. Contact a poison control center or emergency department immediately.

⏰ Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose (within 12 hours), skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose.

Additional Safety Advice

General Safety

This medicine must be taken exactly as prescribed by your oncologist. Do not adjust the dose without consulting your doctor. Take it at the same time each day, with or without food. If you miss a dose, take it as soon as you remember, but if it is almost time for the next dose, skip the missed dose and continue with your regular schedule. Do not double the dose. Diarrhea is a common side effect; your doctor may prescribe anti-diarrheal medicines and advise you to drink plenty of fluids. Report any signs of severe diarrhea, rash, or breathing difficulties immediately. Avoid prolonged sun exposure and use sunscreen, as this medicine can make your skin sensitive to sunlight. Use effective contraception during treatment and for at least two weeks after the last dose, as this medicine can harm a developing baby. Do not breastfeed while taking this medicine. Inform your doctor about all other medicines you are taking, including over-the-counter drugs and herbal supplements, as many can interact with this medicine. Regular blood tests to check liver and kidney function, as well as eye examinations, may be needed. Store this medicine at room temperature away from moisture and heat. Keep out of reach of children.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients may be more sensitive to the side effects of this medicine, especially diarrhea and dehydration. Close monitoring and dose adjustments may be necessary. Ensure adequate fluid intake and monitor kidney function.

🤰 Pregnancy Planning (TTC)

This medicine can cause harm to a developing fetus. Women of childbearing potential should use effective contraception during treatment and for at least 2 weeks after the last dose. If you are planning to become pregnant, discuss with your doctor before stopping the medicine. Men with female partners of childbearing potential should also use effective contraception during treatment and for at least 2 weeks after the last dose.

🏥 Post-Surgery Considerations

If you are planning surgery, inform your surgeon and oncologist that you are taking this medicine. It may need to be stopped temporarily before surgery due to the risk of impaired wound healing and bleeding. Your doctor will advise when to restart.

🦷 Dental Procedures

Inform your dentist that you are taking this medicine before any dental procedure. This medicine can cause mouth sores and may affect healing. Your dentist may recommend postponing elective procedures until your mouth sores have healed. Good oral hygiene is important.

💚 Lifestyle Tips for Better Results

🏃
Maintain good hydration, especially if you have diarrhea.
🥗
Use gentle skin care products and moisturizers to manage rash and dryness.
😴
Avoid prolonged sun exposure and use sunscreen.
💧
Eat a balanced diet and small frequent meals if you have mouth sores or nausea.
🧘
Get adequate rest and pace your activities to manage fatigue.
🌞
Practice good oral hygiene to prevent mouth sores.
🚭
Avoid alcohol as it may worsen side effects.

🏋️ Exercise Considerations

Mild to moderate exercise is generally safe, but if you experience fatigue, dizziness, or diarrhea, avoid strenuous activities. Consult your doctor before starting any new exercise regimen.

🥗 Diet Recommendations

Stay well hydrated with water and oral rehydration solutions if diarrhea occurs.
Eat small, frequent meals if you have nausea or mouth sores.
Avoid spicy, acidic, or rough-textured foods if you have mouth sores.
Include soft, bland foods like bananas, rice, applesauce, and toast if you have diarrhea.
Avoid grapefruit and grapefruit juice.
Limit alcohol consumption.

💼 Impact on Daily Work & Life

This medicine may cause fatigue, diarrhea, and skin rash, which can affect your ability to work or perform daily activities. If you experience dizziness or severe diarrhea, avoid driving or operating heavy machinery. Discuss with your employer about flexible work arrangements if needed.

🛑 When to Stop This Medicine

Do not stop taking this medicine without consulting your doctor. Your doctor may decide to stop treatment if the cancer progresses or if you experience unacceptable side effects. If you need to stop for any reason, your doctor will provide guidance on monitoring and alternative treatments.

📅 Long-Term Use Effects

Long-term use of this medicine may lead to chronic side effects such as persistent diarrhea, skin changes, and nail abnormalities. Regular monitoring of liver, kidney, and lung function is necessary. Some patients may develop resistance to the medicine over time, requiring a change in treatment. Long-term effects on fertility are not fully known. Discuss any concerns with your oncologist.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Other EGFR tyrosine kinase inhibitors

Erlotinib, gefitinib, or osimertinib may be alternatives based on mutation type and prior treatments.

Evidence: Well-established
Chemotherapy

Platinum-based chemotherapy may be used if targeted therapy is not effective or not tolerated.

Evidence: Well-established
Immunotherapy

Immune checkpoint inhibitors may be an option for some patients, but not typically for EGFR-mutated tumors.

Evidence: Limited

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

Live vaccines should be avoided while taking this medicine due to the potential for increased risk of infection. Inactivated vaccines may be given, but their effectiveness may be reduced. Consult your doctor before receiving any vaccinations.

📦 Storage Guide

✅ DO

Store at room temperature (20-25°C)

❌ DON'T

Do not refrigerate

✅ DO

Keep in original container with desiccant

❌ DON'T

Do not transfer to another container

✅ DO

Keep away from moisture and heat

❌ DON'T

Do not store in bathroom

✅ DO

Keep out of reach of children

❌ DON'T

Do not use after expiry date

✈️ Traveling with This Medicine

When traveling, carry this medicine in its original packaging with the prescription label. Bring a copy of your prescription and a doctor&#039;s letter explaining your medical condition and the need for this medicine. Keep it in your carry-on luggage to avoid loss or temperature extremes. Store at room temperature and protect from moisture. If crossing time zones, continue taking your dose at the same time each day according to your home schedule, or adjust as advised by your doctor. Check customs regulations for carrying prescription medicines in your destination country.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 58-year-old woman with EGFR-mutated lung cancer
She started this medicine after genetic testing confirmed an EGFR mutation. Within a few weeks, she experienced diarrhea and a mild skin rash. Her doctor adjusted the dose and prescribed anti-diarrheal medication and topical cream. After two months, imaging showed significant tumor shrinkage. She learned to manage side effects with diet and skin care.
💡 Lesson: Early recognition and management of side effects can help patients continue treatment and achieve good outcomes.
👤 A 65-year-old man with squamous cell lung cancer
He was prescribed this medicine after chemotherapy failed. He initially had mouth sores and fatigue, which made eating difficult. His doctor recommended a soft diet and mouth rinses. With dose reduction, the side effects became manageable, and his cancer remained stable for several months.
💡 Lesson: Dose adjustments and supportive care can improve tolerability without compromising treatment benefit.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: This medicine starts working on cancer cells soon after you begin taking it, but noticeable tumor shrinkage may take several weeks to months. Your doctor will monitor your response with regular scans.

Q: Can I take this medicine with food?

A: Yes, you can take this medicine with or without food. However, avoid grapefruit juice as it can increase the levels of this medicine in your body.

Q: What should I do if I experience diarrhea?

A: Diarrhea is common. Start anti-diarrheal medication as advised by your doctor, drink plenty of fluids, and if it persists or is severe, contact your doctor immediately.

Q: Is this medicine a chemotherapy?

A: No, this medicine is a targeted therapy, not traditional chemotherapy. It specifically blocks proteins that drive cancer cell growth.

Q: Can I stop taking this medicine if I feel better?

A: No, you should continue taking this medicine exactly as prescribed until your doctor tells you to stop. Stopping early may allow the cancer to grow back.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine long-term?
  • Will it affect my kidney function?
  • Can I drive after taking this medicine?
  • Does it interact with my blood pressure medicine?
  • What if I miss a dose?
  • Can I drink alcohol while taking this?
  • Will I lose my hair?
  • Is it safe during pregnancy?

🔄 Substitutes for afmed 30mg tablet

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: Afatinib is a traditional chemotherapy that causes severe hair loss.
    Fact: Afatinib is a targeted therapy, not traditional chemotherapy. Hair loss is uncommon; it primarily causes skin and gastrointestinal side effects.
  • Myth: Afatinib can be taken by anyone with lung cancer.
    Fact: Afatinib is only effective for cancers with specific EGFR mutations. Genetic testing is required before use.
  • Myth: You can stop taking afatinib once you feel better.
    Fact: Afatinib should be continued as prescribed until your doctor advises otherwise, even if you feel better, to keep the cancer under control.

🔄 Alternative Options

Brand Alternatives

📊 Comparison with Similar Medicines

[{"medicine":"Afatinib","class":"2nd generation EGFR TKI","route":"Oral","common_side_effects":"Diarrhea, rash, stomatitis","target":"EGFR, HER2, ErbB3, ErbB4"},{"medicine":"Erlotinib","class":"1st generation EGFR TKI","route":"Oral","common_side_effects":"Rash, diarrhea","target":"EGFR"},{"medicine":"Gefitinib","class":"1st generation EGFR TKI","route":"Oral","common_side_effects":"Rash, diarrhea, liver enzyme elevation","target":"EGFR"},{"medicine":"Osimertinib","class":"3rd generation EGFR TKI","route":"Oral","common_side_effects":"Diarrhea, rash, paronychia","target":"EGFR (including T790M)"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory